Nocturia- therapeutic landscape, Product Description and Pipeline Guide 2019

Posted on 2019-09-30 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, 2019-Sep-30 — /EPR Network/ —The purpose of this MRH research study titled “Nocturia-Pipeline Review, H2 2019” is to enlighten the readers about the Nocturia with a stern focus on the development trends and opportunities projected for future years. In short, this assessment drops light on the market size and revenue share which are motivated by numerous market drivers, together with a clear insight about challenges that might create a blockage for the development of Nocturia.

Get Sample Copy at https://www.marketresearchhub.com/enquiry.php?type=S&repid=2519468

Nocturia – Pipeline Review, H2 2019

Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Nocturia – Pipeline Review, H2 2019, provides an overview of the Nocturia (Genito Urinary System and Sex Hormones) pipeline landscape.

Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of nocturia include congestive heart failure, edema of lower extremities, sleeping disorders such as obstructive sleep apnea, certain drugs, including diuretics (water pills), cardiac glycosides, demeclocycline, lithium, methoxyflurane, phenytoin, propoxyphene, and excessive vitamin d and drinking too much fluid before bedtime, especially coffee, caffeinated beverages, or alcohol. Treatment includes anticholinergic medications.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Nocturia – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Nocturia (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Nocturia (Genito Urinary System and Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Nocturia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III and Phase II stages are 2 and 4 respectively.

Nocturia (Genito Urinary System and Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Nocturia (Genito Urinary System and Sex Hormones).
– The pipeline guide reviews pipeline therapeutics for Nocturia (Genito Urinary System and Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Nocturia (Genito Urinary System and Sex Hormones) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Nocturia (Genito Urinary System and Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Nocturia (Genito Urinary System and Sex Hormones)

Browse Complete Report at https://www.marketresearchhub.com/report/nocturia-pipeline-review-h2-2019-report.html

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Nocturia – Overview
Nocturia – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Nocturia – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Nocturia – Companies Involved in Therapeutics Development
Ferring International Center SA
Roivant Sciences Ltd
Sanwa Kagaku Kenkyusho Co Ltd
Vantia Ltd
Nocturia – Drug Profiles
(acetaminophen + ibuprofen) – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ASP-7035 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
desmopressin acetate – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FE-201836 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fedovapagon – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SK-1404 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Nocturia – Dormant Projects
Nocturia – Discontinued Products
Nocturia – Product Development Milestones
Featured News & Press Releases

Continued………. #@

Make an Enquiry about This Report https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2519468

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick